Vivani Medical, Inc. (VANI)

NASDAQ: VANI · USD

$1.12

-0.02 (-1.8%)· Recorded snapshot

Market cap	101M
Net income (ttm)	-26.3M
EPS (ttm)	-$0.35
Shares out	90.2M
Volume	264,878
Beta	3.30

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -26.3M
EPS (ttm): -$0.35
Market cap: 101M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-220.4

P25 n/aP50 n/aP75 n/a

ROIC-56.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VANI indicators

Market & fundamental data

Available fields

174

Groups with data

Currency

USD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001266806
Company name	Vivani Medical, Inc.
Country	United States
Country code	US
CUSIP number	92854B109
Earnings date	2026-11-12
Earnings time	bmo
Employees	42
Employees change	5
Employees growth	13.51%
Enterprise value	$99M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1998
Industry	Biotechnology
IPO date	2014-11-19
Is primary listing	Yes
Is SPAC	No
ISIN number	US92854B1098
Last 10-K release date	2026-03-26
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$101M
Market cap category	Micro-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$1.12
Price currency	USD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	VANI
U.S. state	California
Website	https://www.vivani.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-31.38%
FCF / EV yield	-26.29%
FCF yield	-25.77%
P/B ratio	5.37x
Price / tangible book value	5.42x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-626,500
ROA	-48.48%
ROA (5Y)	-62.38%
ROCE	-78.21%
ROE	-220.4%
ROE (5Y)	-199.78%
ROIC	-56.66%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	0
Net income growth quarters	1
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.2M
Depreciation and amortization	$478,000
EBIT	$-27.4M
EBITDA	$-26.9M
EPS	$-0.35
FCF per share	$-0.29
Financing cash flow	$39.1M
Free cash flow	$-26.5M
Free cash flow minus SBC	$-27.9M
Investing cash flow	$-1.2M
Net borrowing	$35,000
Net cash flow	$12.7M
Net income	$-26.3M
Operating cash flow minus SBC	$-26.7M
Operating income	$-27.4M
Stock-based compensation	$1.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$0.21
Debt / equity	0.94
Long-term assets	$20M
Long-term liabilities	$16M
Net cash (debt)	$2M
Net cash / market cap	1.98%
Net debt / equity	-0.11
Piotroski F-Score	2
Property, plant and equipment	$19M
Shareholders' equity	$19M
Tangible book value	$19M
Tangible book value per share	$0.21
Total assets	$41.6M
Total cash	$19.9M
Total debt	$17.9M
Total liabilities	$22.7M
WACC	19.09%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$21.6M
Current liabilities	$6.7M
Current ratio	3.25
Net working capital	$-3.1M
Quick ratio	3.09
Working capital	$15M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-29.54%
Dividend yield	0%
Shareholder yield	-29.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$1.26
1D price change	-1.75%
1M price change	-9.68%
1M total return	-9.68%
1W price change	-3.45%
1W total return	-3.45%
1Y price change	-30.86%
1Y return CAGR	-30.88%
1Y total return	-30.86%
20-day SMA	$1.17
200-day SMA	$1.26
3M price change	-13.85%
3M total return	-13.85%
3Y price change	4.67%
3Y return CAGR	1.53%
3Y total return	4.67%
50-day SMA	$1.26
50-day SMA vs 200-day SMA	50over200
52-week high	$1.81
52-week high date	2025-10-29
52-week low	$0.92
52-week low date	2026-03-30
6M price change	-19.42%
6M total return	-19.42%
All-time high	$7.80
All-time high date	2024-02-28
All-time low	$0.75
All-time low date	2023-04-06
Average true range (ATR)	$0.05
Average volume	161.6K
Beta (1Y)	2.44
Beta (2Y)	1.31
Beta (5Y)	3.3
Change from 52-week high	-38.12%
Change from 52-week low	21.37%
Change from all-time high	-85.64%
Change from all-time low	48.62%
Change from open	-2.18%
Day's gap	0.44%
Dollar volume	$296,663
High price	$1.15
Low price	$1.06
Monthly RSI	43.08
Open price	$1.15
Position in 52-week range	70.59%
Premarket change	4.32%
Premarket close	$1.14
Premarket price	$1.19
Premarket volume	2.2K
Previous close	$1.14
Price vs 150-day SMA	-10.83%
Price vs 20-day SMA	-4.44%
Price vs 200-day SMA	-10.97%
Price vs 50-day SMA	-11.04%
Relative volume	1.65
RSI	39.97
Sharpe ratio	-0.33
Sharpe ratio (3Y)	0.39
Sortino ratio	-0.4
Sortino ratio (3Y)	1.63
Volume	264.9K
Weekly RSI	42.29
YTD price change	-8.94%
YTD total return	-8.94%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38.9M
Float percentage	43.17%
Shares change (QoQ)	7.16%
Shares change (YoY)	29.54%
Shares held by insiders	49.89%
Shares held by institutions	7.04%
Shares outstanding	90.2M
Short % of float	1.33%
Short % of shares	0.58%
Short ratio	2.2 days

Deeper analysis on VANI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VANI report

Is a complete VANI research report available?

No complete published report is available for Vivani Medical, Inc. (VANI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Vivani Medical, Inc. (VANI)

Price

Financial snapshot

Fair-value bridge

Latest news · VANI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VANI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VANI

Frequently asked questions